A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptors

DIvyan A. Chopra, Kiran Sapkota, Mark W. Irvine, Guangyu Fang, David E. Jane, Daniel T. Monaghan, Shashank M. Dravid

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

NMDA receptors (NMDARs) contribute to several neuropathological processes. Novel positive allosteric modulators (PAMs) of NMDARs have recently been identified but their effects on NMDAR gating remain largely unknown. To this end, we tested the effect of a newly developed molecule UBP684 on GluN1/GluN2A receptors. We found that UBP684 potentiated the whole-cell currents observed under perforated-patch conditions and slowed receptor deactivation. At the single channel level, UBP684 produced a dramatic reduction in long shut times and a robust increase in mean open time. These changes were similar to those produced by NMDAR mutants in which the ligand-binding domains (LBDs) are locked in the closed clamshell conformation by incorporating a disulfide bridge. Since the locked glutamate-binding clefts primarily contributes to receptor efficacy these results suggests that UBP684 binding may induce switch in conformation similar to glutamate LBD locked state. Consistent with this prediction UBP684 displayed greater potentiation of NMDARs with only the GluN1 LBD locked compared to NMDARs with only the GluN2 LBD locked. Docking studies suggest that UBP684 binds to the GluN1 and GluN2 LBD interface supporting its potential ability in stabilizing the LBD closed conformation. Together these studies identify a novel pharmacological mechanism of facilitating the function of NMDARs.

Original languageEnglish (US)
Article number6933
JournalScientific Reports
Volume7
Issue number1
DOIs
StatePublished - Dec 1 2017

Fingerprint

N-Methyl-D-Aspartate Receptors
Pharmacology
Ligands
Glutamic Acid
Disulfides

All Science Journal Classification (ASJC) codes

  • General

Cite this

A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptors. / Chopra, DIvyan A.; Sapkota, Kiran; Irvine, Mark W.; Fang, Guangyu; Jane, David E.; Monaghan, Daniel T.; Dravid, Shashank M.

In: Scientific Reports, Vol. 7, No. 1, 6933, 01.12.2017.

Research output: Contribution to journalArticle

Chopra, DIvyan A. ; Sapkota, Kiran ; Irvine, Mark W. ; Fang, Guangyu ; Jane, David E. ; Monaghan, Daniel T. ; Dravid, Shashank M. / A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptors. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{725c716b70924af39e8c2819040e3280,
title = "A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptors",
abstract = "NMDA receptors (NMDARs) contribute to several neuropathological processes. Novel positive allosteric modulators (PAMs) of NMDARs have recently been identified but their effects on NMDAR gating remain largely unknown. To this end, we tested the effect of a newly developed molecule UBP684 on GluN1/GluN2A receptors. We found that UBP684 potentiated the whole-cell currents observed under perforated-patch conditions and slowed receptor deactivation. At the single channel level, UBP684 produced a dramatic reduction in long shut times and a robust increase in mean open time. These changes were similar to those produced by NMDAR mutants in which the ligand-binding domains (LBDs) are locked in the closed clamshell conformation by incorporating a disulfide bridge. Since the locked glutamate-binding clefts primarily contributes to receptor efficacy these results suggests that UBP684 binding may induce switch in conformation similar to glutamate LBD locked state. Consistent with this prediction UBP684 displayed greater potentiation of NMDARs with only the GluN1 LBD locked compared to NMDARs with only the GluN2 LBD locked. Docking studies suggest that UBP684 binds to the GluN1 and GluN2 LBD interface supporting its potential ability in stabilizing the LBD closed conformation. Together these studies identify a novel pharmacological mechanism of facilitating the function of NMDARs.",
author = "Chopra, {DIvyan A.} and Kiran Sapkota and Irvine, {Mark W.} and Guangyu Fang and Jane, {David E.} and Monaghan, {Daniel T.} and Dravid, {Shashank M.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-07292-8",
language = "English (US)",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptors

AU - Chopra, DIvyan A.

AU - Sapkota, Kiran

AU - Irvine, Mark W.

AU - Fang, Guangyu

AU - Jane, David E.

AU - Monaghan, Daniel T.

AU - Dravid, Shashank M.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - NMDA receptors (NMDARs) contribute to several neuropathological processes. Novel positive allosteric modulators (PAMs) of NMDARs have recently been identified but their effects on NMDAR gating remain largely unknown. To this end, we tested the effect of a newly developed molecule UBP684 on GluN1/GluN2A receptors. We found that UBP684 potentiated the whole-cell currents observed under perforated-patch conditions and slowed receptor deactivation. At the single channel level, UBP684 produced a dramatic reduction in long shut times and a robust increase in mean open time. These changes were similar to those produced by NMDAR mutants in which the ligand-binding domains (LBDs) are locked in the closed clamshell conformation by incorporating a disulfide bridge. Since the locked glutamate-binding clefts primarily contributes to receptor efficacy these results suggests that UBP684 binding may induce switch in conformation similar to glutamate LBD locked state. Consistent with this prediction UBP684 displayed greater potentiation of NMDARs with only the GluN1 LBD locked compared to NMDARs with only the GluN2 LBD locked. Docking studies suggest that UBP684 binds to the GluN1 and GluN2 LBD interface supporting its potential ability in stabilizing the LBD closed conformation. Together these studies identify a novel pharmacological mechanism of facilitating the function of NMDARs.

AB - NMDA receptors (NMDARs) contribute to several neuropathological processes. Novel positive allosteric modulators (PAMs) of NMDARs have recently been identified but their effects on NMDAR gating remain largely unknown. To this end, we tested the effect of a newly developed molecule UBP684 on GluN1/GluN2A receptors. We found that UBP684 potentiated the whole-cell currents observed under perforated-patch conditions and slowed receptor deactivation. At the single channel level, UBP684 produced a dramatic reduction in long shut times and a robust increase in mean open time. These changes were similar to those produced by NMDAR mutants in which the ligand-binding domains (LBDs) are locked in the closed clamshell conformation by incorporating a disulfide bridge. Since the locked glutamate-binding clefts primarily contributes to receptor efficacy these results suggests that UBP684 binding may induce switch in conformation similar to glutamate LBD locked state. Consistent with this prediction UBP684 displayed greater potentiation of NMDARs with only the GluN1 LBD locked compared to NMDARs with only the GluN2 LBD locked. Docking studies suggest that UBP684 binds to the GluN1 and GluN2 LBD interface supporting its potential ability in stabilizing the LBD closed conformation. Together these studies identify a novel pharmacological mechanism of facilitating the function of NMDARs.

UR - http://www.scopus.com/inward/record.url?scp=85024369553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024369553&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-07292-8

DO - 10.1038/s41598-017-07292-8

M3 - Article

C2 - 28761055

AN - SCOPUS:85024369553

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 6933

ER -